Therapeutic Research for Various Diseases via Macrophage Polarization Control
Targeting Fibrosis and Ovarian Cancer through Immune Microenvironment Modulation
Targeting Fibrosis and Ovarian Cancer through Immune Microenvironment Modulation
Successful restoration of uterine and pulmonary tissue by inducing M2 polarization.
Enhanced anti-tumor activity in ovarian cancer via M1 phenotype activation.
Synergistic tumor suppression when combined with Paclitaxel treatment.
Core technology protected under Patent No. 10-2635831 and others.
Developing therapeutic strategies to reverse fibrotic changes in the uterus and lungs by modulating the macrophage-mediated inflammatory response.
Researching the efficacy of macrophage polarization in suppressing ovarian cancer progression and improving the delivery of chemotherapeutic agents.
Investigating the molecular signals that govern the plastic nature of macrophages to switch between pro-tumor and anti-tumor states.
Analyzing the interaction between tumor cells and macrophages to prevent immune evasion and enhance the body's natural defense mechanisms.